Patients Less Likely to Experience Death at Academic and High-Volume Hospitals When Treated with Immunotherapy for Metastatic Cancers

A new study led by Yale Cancer Center researchers at Yale School of Medicine revealed a significant increase in patients starting immunotherapy within one month

Related Keywords

United States ,Alexander Frey ,Elizabeth Prsic ,Sajid Khan ,Thuy Tran ,Mario Sznol ,Daniel Kerekes ,Robert Becher ,James Clune ,Howard Forman ,Kelly Olino ,Harriet Kluger ,Yale Department Of Surgery ,Yale Cancer Center ,Yale School Of Medicine ,Tumors At Yale School Of Medicine ,Team Science At Yale Center ,Yale School ,Mixed Tumors ,Steam Science ,Yale Center ,Yale Department ,Newswise ,Etastatic Cancers Death Immunotherapy ,All Journal News ,Dancer ,Mmunology ,Yale Cancer Center Smilow Hospital ,